STOCK TITAN

[SCHEDULE 13G/A] Forte Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Please see note in Item 4(a)


SCHEDULE 13G




Comment for Type of Reporting Person: Please see note in Item 4(a)


SCHEDULE 13G



Boothbay Fund Management, LLC
Signature:Ari Glass
Name/Title:Ari Glass, Managing Member
Date:08/07/2025
Ari Glass
Signature:Ari Glass
Name/Title:Individually
Date:08/07/2025
Exhibit Information

Exhibit I - JOINT FILING STATEMENT

Forte Biosciences Inc

NASDAQ:FBRX

FBRX Rankings

FBRX Latest News

FBRX Latest SEC Filings

FBRX Stock Data

118.47M
11.00M
9.37%
99.06%
1.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
DALLAS